Designing dendrimer-based lymphatic drug vectors as improved treatments for metastatic cancer

该项目建立在澳大利亚的研究实力领域（纳米技术和生物技术/生物材料），并将大大增加澳大利亚在树突技术方面的专业知识基础（澳大利亚在这方面处于世界领先地位）。该项目将推进支撑树突分子设计的基础科学基础，并有可能在改善药物输送方面带来实质性好处，从而为澳大利亚带来健康结果。该项目的跨学科性质也将为参与的研究人员提供独特的培训计划。澳大利亚非常需要这种经验，因为发展中的生物技术和纳米技术行业严重缺乏具有药物输送技能的科学家。

This project builds on areas of research strength in Australia (nanotechnology and biotechnology/biomaterials) and will add considerably to the expanding Australian expertise-base in dendrimer technology (in which it is a world leader). The project will advance the fundamental science base that underpins dendrimer design and has the potential to deliver substantial benefits in improved drug delivery and therefore health outcomes for Australia. The interdisciplinary nature of this project will also result in a unique training program for the researchers involved. Such experience is in great demand in Australia where the developing biotechnology and nanotechnology industry is critically short of scientists with skills in drug delivery.